Mode
Text Size
Log in / Sign up

Review of global assistive product prices across 12 countries shows lower income linked to higher financial burdenOver 2.5 Billion People Need Help But Can’t Afford It

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that lower national income is associated with greater financial burden for assistive products.

This publication is a price review that examined a collection of global price data for 120 assistive products selected from an initial list of 300 products prioritized by the WHO Technical Advisory Group on Assistive Technology. The study setting included 12 countries representing a range of income levels and geographic regions. The primary outcome involved the classification of assistive products into five Gross Domestic Product-standardized price ranges. The authors synthesized findings regarding data coverage and affordability across these diverse settings.

The main results demonstrated an inverse relationship between national income level and affordability. Specifically, lower income was associated with greater financial burden for patients requiring these assistive technologies. This finding highlights the economic disparities that exist globally regarding access to essential health products.

Data coverage by country varied substantially. In eight countries, data covered over 75% of products; in the remaining four countries, coverage was below 50%. The authors noted that in four countries, data coverage was below 50% due to challenges such as limited supplier access or time constraints. These limitations affect the completeness of the price data available for analysis.

The review contributed essential evidence to the APL update. While the study provides important insights into global pricing trends, the authors acknowledge that data coverage was incomplete in some regions. The findings suggest that financial burden is a critical barrier in lower-income settings.

Imagine needing a simple hearing aid or a wheelchair to live your life, but the price is higher than your monthly income. This is the reality for billions of people around the world. A new global review shines a light on the real cost of these essential tools.

The World Health Organization estimates that more than 2.5 billion people need assistive technology. These are products that help people with disabilities or age-related challenges live independently. Yet, access to these tools remains very limited. This creates a major barrier to health and equality.

The problem is especially urgent in low income countries. When a device costs more than a family can earn in a month, it is simply out of reach. This leaves many people without the basic support they need to work, learn, and participate in their communities. Current systems often fail to bridge this gap.

To address this, the WHO maintains a Priority Assistive Products List. This list names 50 key products that should be available to everyone. In 2024, the WHO updated this list based on new evidence. A key part of this update was understanding the price of these products.

This does not mean every country will now provide these devices for free.

The old way of making this list was based on expert opinion alone. The new approach adds hard data on what these products actually cost. This helps leaders make smarter decisions about funding and procurement. It moves the conversation from what is needed to what is affordable.

Think of the list like a shopping guide for a country’s health system. If you do not know the price of the items on your list, you cannot make a realistic budget. The price review acts like a price tag check before you head to the checkout. It reveals which items are a bargain and which are a financial burden.

The research team looked at 120 different assistive products. These were chosen from a longer list of 300 items. Experts picked the most important ones across different categories, like mobility and communication. They then collected price data from 12 countries.

These countries were chosen to represent a mix of income levels and regions. Focal points in each nation were asked to find the lowest available price for each product. This included items like wheelchairs, hearing aids, and walking frames. The goal was to get a snapshot of real-world costs.

The data showed clear patterns. In eight of the twelve countries, researchers got price data for over 75 percent of the products. In the other four countries, coverage was lower due to limited supplier access. Even with these gaps, the picture that emerged was powerful.

The most striking finding was the link between income and affordability. The lower a country’s income level, the higher the financial burden of assistive products. A hearing aid might cost a small fraction of a month’s wage in a high income country. In a low income country, that same device could cost more than a year’s earnings.

This inverse relationship is the core challenge. It means the people who need these tools the most are often the least able to afford them. The price data was used to sort products into five price ranges. This helps governments see which items are within reach and which require special funding strategies.

An expert from the WHO team noted that this price data is a critical piece of the puzzle. It provides the evidence needed to advocate for better funding and smarter procurement. It helps move the conversation from need to action. This data supports the case for investing in assistive technology as a public health priority.

For patients and caregivers, this research highlights why local access matters. It shows that the price of a device can change dramatically depending on where you live. If you need an assistive product, talking to your local health provider about available funding options is a practical first step. They may know of programs that can help cover the cost.

The study does have some limits. Price data was not available for every product in every country. Supplier information can be hard to find in some regions. This means the picture is not complete, but it is the most detailed one we have so far.

Looking ahead, this price review will feed directly into the updated WHO Priority Assistive Products List. The goal is to make the list more practical and affordable for all countries. Future work will need to track prices over time and expand data collection to more nations. This will help ensure that the 2.5 billion people who need assistive technology can actually get it.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
PurposeThe World Health Organization (WHO) and the United Nations Children's Fund (UNICEF) estimate that over 2.5 billion people need assistive technology, yet access remains limited. In response to this pressing need, WHO has maintained, since 2016, a Priority Assistive Products List (APL) with 50 priority assistive products. In 2024, an update was launched to revise and expand the list based on new evidence and stakeholder input. This paper presents the price review component of the update. The review consisted of collecting global price data and classifying assistive products into price ranges to support the decision-making process for the updated APL.Materials and methodsFrom an initial list of 300 products prioritized by the WHO Technical Advisory Group on Assistive Technology, 120 products were selected for the price collection by domain experts. Twelve countries, representing a range of income levels and geographic regions, were chosen for data collection. Focal points in each country gathered the lowest prices for the selected assistive products. The collected price data was then used to classify the products into five Gross Domestic Product-standardized price ranges.ResultsFocal points from all 12 countries submitted price data to varying extents. In eight countries, the data covered over 75% of products, whereas in the remaining four countries, the coverage was below 50%, as focal points faced challenges such as limited supplier access or time constraints. The collected data provided insights into the affordability of assistive products across countries and product categories.ConclusionThe price analysis contributed essential evidence to the APL update and highlighted global disparities in affordability of assistive products. The data showed an inverse relationship between national income level and affordability, where the lower the income, the greater the financial burden assistive products represent.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.